Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 22, 2025. (Total: 235574Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 8 (of 8 Records)

Query Trace: Schizophrenia and KMO[original query]
Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population.
Genes, brain, and behavior 2006 Jun 5 (4): 364-8.
Aoyama N, Takahashi N, Saito S, Maeno N, Ishihara R, Ji X, Miura H, Ikeda M, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Yoshida K, Iwata N, Inada T, Ozaki
Kynurenine 3-monooxygenase (KMO) polymorphisms in schizophrenia: an association study.
Schizophrenia research 2011 Apr 127 (1-3): 270-2.
Holtze Maria, Saetre Peter, Erhardt Sophie, Schwieler Lilly, Werge Thomas, Hansen Thomas, Nielsen Jimmi, Djurovic Srdjan, Melle Ingrid, Andreassen Ole A, Hall Håkan, Terenius Lars, Agartz Ingrid, Engberg Göran, Jönsson Erik G, Schalling Mart
Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.
Archives of general psychiatry 2011 Jul 68 (7): 665-74.
Wonodi Ikwunga, Stine O Colin, Sathyasaikumar Korrapati V, Roberts Rosalinda C, Mitchell Braxton D, Hong L Elliot, Kajii Yasushi, Thaker Gunvant K, Schwarcz Robe
Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls.
Journal of psychiatry & neuroscience : JPN 2011 Jul 36 (4): 4.
Holtze M, Saetre P, Engberg G, Schwieler L, Werge T, Andreassen OA, Hall H, Terenius L, Agartz I, Jönsson EG, Schalling M, Erhardt S
The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.
Molecular psychiatry 2014 Mar 19 (3): 334-41.
Lavebratt C, Olsson S, Backlund L, Frisén L, Sellgren C, Priebe L, Nikamo P, Träskman-Bendz L, Cichon S, Vawter M P, Osby U, Engberg G, Landén M, Erhardt S, Schalling
Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia.
Schizophrenia research 2014 Dec 160 (1-3): 80-7.
Wonodi Ikwunga, McMahon Robert P, Krishna Nithin, Mitchell Braxton D, Liu Judy, Glassman Matthew, Hong L Elliot, Gold James
Cerebrospinal fluid monoamine metabolite concentrations as intermediate phenotypes between glutamate-related genes and psychosis.
Psychiatry research 2015 Sep 229 (1-2): 497-504.
Andreou Dimitrios, Söderman Erik, Axelsson Tomas, Sedvall Göran C, Terenius Lars, Agartz Ingrid, Jönsson Erik
Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine.
Schizophrenia research. Cognition 2016 Jun 4 4-9.
Koola Maju Math
TOP